"You decide and we provide."
Cart 0

UPDATE 2-Novartis sets sights on return to growth in 2018




reutersCOMPANYNEWS companyNews

* Advances MS drug BAF312 filing date to 2018 from 2019 (Recasts to focus on growth outlook in 2018, adds analyst comments, details)




Older Post Newer Post


Leave a comment

Please note, comments must be approved before they are published